These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28855409)

  • 1. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
    Hilbert JE; Barohn RJ; Clemens PR; Luebbe EA; Martens WB; McDermott MP; Parkhill AL; Tawil R; Thornton CA; Moxley RT;
    Neurology; 2017 Sep; 89(13):1348-1354. PubMed ID: 28855409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
    Tieleman AA; van Vliet J; Jansen JB; van der Kooi AJ; Borm GF; van Engelen BG
    Neuromuscul Disord; 2008 Aug; 18(8):646-9. PubMed ID: 18602828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
    Berends J; Tieleman AA; Horlings CGC; Smulders FHP; Voermans NC; van Engelen BGM; Raaphorst J
    Neuromuscul Disord; 2019 Oct; 29(10):758-765. PubMed ID: 31540818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
    Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
    Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milestones of progression in myotonic dystrophy type 1 and type 2.
    Hamel JI; McDermott MP; Hilbert JE; Martens WB; Luebbe E; Tawil R; Moxley RT; Thornton CA
    Muscle Nerve; 2022 Oct; 66(4):508-512. PubMed ID: 35778789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.
    Bianchi ML; Losurdo A; Di Blasi C; Santoro M; Masciullo M; Conte G; Valenza V; Damiani A; Della Marca G; Silvestri G
    Sleep Breath; 2014 Sep; 18(3):579-89. PubMed ID: 24310756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidimensional aspects of pain in myotonic dystrophies.
    Peric M; Peric S; Rapajic N; Dobricic V; Savic-Pavicevic D; Nesic I; Radojicic S; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Myol; 2015 Dec; 34(2-3):126-32. PubMed ID: 27199540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy.
    Vanacore N; Rastelli E; Antonini G; Bianchi ML; Botta A; Bucci E; Casali C; Costanzi-Porrini S; Giacanelli M; Gibellini M; Modoni A; Novelli G; Pennisi EM; Petrucci A; Piantadosi C; Silvestri G; Terracciano C; Massa R
    Neuroepidemiology; 2016; 46(3):191-7. PubMed ID: 26882032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
    Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
    Higgs C; Hilbert JE; Wood L; Martens WB; Marini-Bettolo C; Nikolenko N; Alsaggaf R; Lochmüller H; Moxley RT; Greene MH; Wang Y; Gadalla SM
    Front Neurol; 2019; 10():1071. PubMed ID: 31681146
    [No Abstract]   [Full Text] [Related]  

  • 18. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.